Annual Accounts Payable
$4.82 M
+$2.85 M+145.22%
December 31, 2024
Summary
- As of March 7, 2025, CRDF annual accounts payable is $4.82 million, with the most recent change of +$2.85 million (+145.22%) on December 31, 2024.
- During the last 3 years, CRDF annual accounts payable has risen by +$3.38 million (+235.02%).
- CRDF annual accounts payable is now at all-time high.
Performance
CRDF Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$4.82 M
+$178.00 K+3.83%
December 31, 2024
Summary
- As of March 7, 2025, CRDF quarterly accounts payable is $4.82 million, with the most recent change of +$178.00 thousand (+3.83%) on December 31, 2024.
- Over the past year, CRDF quarterly accounts payable has increased by +$178.00 thousand (+3.83%).
- CRDF quarterly accounts payable is now -7.13% below its all-time high of $5.19 million, reached on March 31, 2024.
Performance
CRDF Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CRDF Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +145.2% | +3.8% |
| 3 y3 years | +235.0% | +282.3% |
| 5 y5 years | +634.6% | +282.3% |
CRDF Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +235.0% | -7.1% | +282.3% |
| 5 y | 5-year | at high | +634.6% | -7.1% | +1117.4% |
| alltime | all time | at high | +2643.9% | -7.1% | +3343.6% |
Cardiff Oncology Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $4.82 M(+145.2%) | $4.82 M(+3.8%) |
| Sep 2024 | - | $4.64 M(-9.1%) |
| Jun 2024 | - | $5.11 M(-1.6%) |
| Mar 2024 | - | $5.19 M(+164.0%) |
| Dec 2023 | $1.97 M(+0.5%) | $1.97 M(-9.8%) |
| Sep 2023 | - | $2.18 M(-25.9%) |
| Jun 2023 | - | $2.94 M(+0.9%) |
| Mar 2023 | - | $2.91 M(+49.0%) |
| Dec 2022 | $1.96 M(+35.9%) | $1.96 M(+37.3%) |
| Sep 2022 | - | $1.43 M(-6.4%) |
| Jun 2022 | - | $1.52 M(+20.7%) |
| Mar 2022 | - | $1.26 M(-12.4%) |
| Dec 2021 | $1.44 M(+5.3%) | $1.44 M(+263.4%) |
| Sep 2021 | - | $396.00 K(-27.1%) |
| Jun 2021 | - | $543.00 K(-32.4%) |
| Mar 2021 | - | $803.00 K(-41.2%) |
| Dec 2020 | $1.37 M(+108.1%) | $1.37 M(+123.9%) |
| Sep 2020 | - | $610.20 K(-47.2%) |
| Jun 2020 | - | $1.16 M(+92.9%) |
| Mar 2020 | - | $599.00 K(-8.7%) |
| Dec 2019 | $656.30 K(-1.3%) | $656.30 K(+33.3%) |
| Sep 2019 | - | $492.40 K(-6.3%) |
| Jun 2019 | - | $525.70 K(+12.6%) |
| Mar 2019 | - | $466.70 K(-29.8%) |
| Dec 2018 | $664.80 K | $664.80 K(+39.6%) |
| Sep 2018 | - | $476.30 K(-15.8%) |
| Jun 2018 | - | $565.40 K(-13.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $651.70 K(-21.0%) |
| Dec 2017 | $825.20 K(-27.0%) | $825.20 K(+22.2%) |
| Sep 2017 | - | $675.50 K(+12.1%) |
| Jun 2017 | - | $602.70 K(-37.8%) |
| Mar 2017 | - | $968.40 K(-14.3%) |
| Dec 2016 | $1.13 M(+8.6%) | $1.13 M(+22.2%) |
| Sep 2016 | - | $925.20 K(-17.0%) |
| Jun 2016 | - | $1.12 M(-14.0%) |
| Mar 2016 | - | $1.30 M(+24.6%) |
| Dec 2015 | $1.04 M(+39.2%) | $1.04 M(-5.4%) |
| Sep 2015 | - | $1.10 M(-1.0%) |
| Jun 2015 | - | $1.11 M(+129.2%) |
| Mar 2015 | - | $484.70 K(-35.2%) |
| Dec 2014 | $747.80 K(+160.9%) | $747.80 K(+61.9%) |
| Sep 2014 | - | $461.80 K(+21.6%) |
| Jun 2014 | - | $379.70 K(-11.2%) |
| Mar 2014 | - | $427.40 K(+49.1%) |
| Dec 2013 | $286.60 K(+63.1%) | $286.60 K(+80.3%) |
| Sep 2013 | - | $159.00 K(-46.6%) |
| Jun 2013 | - | $297.80 K(-7.9%) |
| Mar 2013 | - | $323.40 K(+84.1%) |
| Dec 2012 | $175.70 K(-81.1%) | $175.70 K(+25.5%) |
| Sep 2012 | - | $140.00 K(-73.6%) |
| Jun 2012 | - | $530.80 K(-43.9%) |
| Mar 2012 | - | $947.00 K(+2.0%) |
| Dec 2011 | $928.40 K(+45.5%) | $928.40 K |
| Dec 2010 | $637.90 K | - |
FAQ
- What is Cardiff Oncology annual accounts payable?
- What is the all time high annual accounts payable for Cardiff Oncology?
- What is Cardiff Oncology annual accounts payable year-on-year change?
- What is Cardiff Oncology quarterly accounts payable?
- What is the all time high quarterly accounts payable for Cardiff Oncology?
- What is Cardiff Oncology quarterly accounts payable year-on-year change?
What is Cardiff Oncology annual accounts payable?
The current annual accounts payable of CRDF is $4.82 M
What is the all time high annual accounts payable for Cardiff Oncology?
Cardiff Oncology all-time high annual accounts payable is $4.82 M
What is Cardiff Oncology annual accounts payable year-on-year change?
Over the past year, CRDF annual accounts payable has changed by +$2.85 M (+145.22%)
What is Cardiff Oncology quarterly accounts payable?
The current quarterly accounts payable of CRDF is $4.82 M
What is the all time high quarterly accounts payable for Cardiff Oncology?
Cardiff Oncology all-time high quarterly accounts payable is $5.19 M
What is Cardiff Oncology quarterly accounts payable year-on-year change?
Over the past year, CRDF quarterly accounts payable has changed by +$178.00 K (+3.83%)